Literature DB >> 33189614

Non-infectious outer membrane vesicles derived from Brucella abortus S19Δper as an alternative acellular vaccine protects mice against virulent challenge.

Khushal Singh Solanki1, Rajat Varshney2, Salauddin Qureshi3, Prasad Thomas4, Rahul Singh5, Aditya Agrawal6, Pallab Chaudhuri7.   

Abstract

The prime human and animal safety issues accentuate the search of promising newer alternative vaccine candidates to resolve complications associated with the live attenuated Brucella abortus strain19 (S19) vaccine. Outer membrane vesicles (OMVs S19 Δper) extracted from Brucella abortus S19Δper (S19Δper) as an alternative subunit vaccine candidate has been explored in the present study as OMVs are endowed with immunogenic molecules, including LPS and outer membrane proteins (OMPs) and do not cause infection by virtue of being an acellular entity. The LPS defective S19Δper released a higher amount of OMVs than its parent strain S19. Under transmission electron microscopy (TEM), OMVs were seen as nano-sized outward bulge from the surface of Brucella. Dynamic light scattering analysis of OMVs revealed that OMVs S19Δper showed the less polydispersity index (PDI) than OMVs S19 pointing towards relatively more homogenous OMVs populations. Both OMVs S19Δper and OMVs S19 with or without booster dose and S19 vaccine were used for immunization of mice and subsequently challenged with 2 × 105 CFU virulent Brucella abortus strain 544 (S544) to assess protective efficacy of vaccines. The less splenic weight index and less S544 count in OMVs immunized mice in comparison to unimmunized mice after S544 challenge clearly indicated good protective efficacy of OMVs. OMVs S19 Δper induced relatively high titer of IgG than OMVs S19 but conferred nearly equal protection against brucellosis. An ELISA based determination of IgG and its isotype response, Cytometric Bead Array (CBA) based quantitation of serum cytokines and FACS based enumeration of CD4+ and CD8+ T cells revealed high titer of IgG, production of both Th1 (IgG2a) and Th2 (IgG1) related antibodies, stimulation of IL-2, TNF (Th1) and IL-4, IL-6, IL-10 (Th2) cytokines, and induced T cell response suggested that OMVs S19Δper elicited Th1 and Th2 type immune response and ensured protection against S544 challenge in murine model.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Brucellosis; Immune response; OMVs S19; OMVs S19Δper; Vaccine

Mesh:

Substances:

Year:  2020        PMID: 33189614     DOI: 10.1016/j.intimp.2020.107148

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  4 in total

Review 1.  Exosomes: Biological Pharmaceutical Nanovectors for Theranostics.

Authors:  Shindu C Thomas; Jin-Woo Kim; Giovanni M Pauletti; Daniel J Hassett; Nalinikanth Kotagiri
Journal:  Front Bioeng Biotechnol       Date:  2022-01-12

2.  Proteome Analysis of Outer Membrane Vesicles From a Highly Virulent Strain of Haemophilus parasuis.

Authors:  Kunli Zhang; Pinpin Chu; Shuai Song; Dongxia Yang; Zhibiao Bian; Yan Li; Hongchao Gou; Zhiyong Jiang; Rujian Cai; Chunling Li
Journal:  Front Vet Sci       Date:  2021-11-26

3.  Brucella melitensis Wzm/Wzt System: Changes in the Bacterial Envelope Lead to Improved Rev1Δwzm Vaccine Properties.

Authors:  Sara Mena-Bueno; Irati Poveda-Urkixo; Oihane Irazoki; Leyre Palacios; Felipe Cava; Ana Zabalza-Baranguá; María Jesús Grilló
Journal:  Front Microbiol       Date:  2022-07-04       Impact factor: 6.064

Review 4.  Evaluation of Brucellosis Vaccines: A Comprehensive Review.

Authors:  Mohsen Heidary; Shirin Dashtbin; Roya Ghanavati; Marzie Mahdizade Ari; Narjess Bostanghadiri; Atieh Darbandi; Tahereh Navidifar; Malihe Talebi
Journal:  Front Vet Sci       Date:  2022-07-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.